Market Overview:
The global kanamycin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for kanamycin due to its antimicrobial properties and rising prevalence of infectious diseases. In addition, the growing use of kanamycin in medical and scientific research applications is also contributing to the growth of this market. However, factors such as stringent regulatory requirements and high costs associated with R&D are restraining the growth of this market. On the basis of type, the global kanamycin market can be segmented into injection and solution products. The injection product segment is expected to account for a larger share than that of solution products in terms revenue contribution during 2018-2030 owing higher adoption rates across various end-use industries including medical, scientific research, and others segments collectively).
Product Definition:
A bacteriostatic antibiotic produced by Streptomyces kanamyceticus, used to treat a wide variety of infections.
Injection:
Injection is a method of medication that involves the administration of drugs into the bloodstream through syringes or intravenous catheters. Injectables are different from oral medications in terms of their mode of action and site of action. The drug absorption process in injectables is rapid, which offers an advantage to this form over other dosage forms; it allows for higher doses to be administered without having an adverse effect on the patient's health.
Solution:
Kanamycin is a type of antimicrobial drug used to treat bacterial infections. It works by killing the bacteria. The most common types of bacterial infections that kenneths lawsonia dolioides (lawsonia bug) can cause are ear, eye, and skin infections; pneumonia; and bloodstream infection. Kanamycin has been approved by the Food and Drug Administration (FDA) for use as a prescription drug in the U.S.
Application Insights:
Medical application of kanamycin includes the use of injection for the treatment of infections caused by susceptible bacteria. The medical segment held a major share in 2015 and is expected to maintain its dominance over the forecast period. This is attributed to extensive usage as an antibiotic for various diseases, such as tuberculosis, skin infections, respiratory tract infections, UTI's (urinary tract infection), ear infection etc. It has also been used in surgical procedures and can be used against drug-resistant bacteria & viruses.
The other segment comprises research applications where kanamycin is used for scientific research purposes or animal testing purposes only; it does not have any commercial application whatsoever.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing R&D activities and rising healthcare spending in emerging economies such as China, India, and South Korea. In addition, growing awareness regarding kanamycin-based products among healthcare professionals and patients is further expected to drive demand for kanamycin in this region.
In addition, favorable government initiatives pertaining to research & development activities are also anticipated to propel growth of the Asia Pacific market during the forecast period. For instance; ‘Make in India’ initiative by Indian government aims at promoting manufacturing sector within country which will create job opportunities for skilled labor thus driving demand for kanamycin-based drugs over next few years .
Growth Factors:
- Increasing demand for kanamycin in the pharmaceutical and biotechnology industries for the manufacture of antibiotics, antitumor drugs, and other therapeutic agents.
- Rising prevalence of infectious diseases that are treated with kanamycin-based antibiotics.
- Growing demand for kanamycin as a research tool in the fields of molecular biology and genetics.
- increasing use of kanamycin as a feed additive to promote livestock growth and improve meat quality . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Kanamycin Market Research Report
By Type
Injection, Solution
By Application
Medical, Santific Research, Other
By Companies
Thermo Fisher, Sigma-Aldrich, HiMedia, Atlanta Biologicals, Takara, PromoCell, Zenbio, Abcam
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Kanamycin Market Report Segments:
The global Kanamycin market is segmented on the basis of:
Types
Injection, Solution
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Santific Research, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Sigma-Aldrich
- HiMedia
- Atlanta Biologicals
- Takara
- PromoCell
- Zenbio
- Abcam
Highlights of The Kanamycin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Solution
- By Application:
- Medical
- Santific Research
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Kanamycin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Kanamycin is a type of antibiotic that is used to treat infections. It works by killing the bacteria cells that are causing the infection. Kanamycin can be taken by mouth or injected into a vein.
Some of the key players operating in the kanamycin market are Thermo Fisher, Sigma-Aldrich, HiMedia, Atlanta Biologicals, Takara, PromoCell, Zenbio, Abcam.
The kanamycin market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Kanamycin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Kanamycin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Kanamycin Market - Supply Chain
4.5. Global Kanamycin Market Forecast
4.5.1. Kanamycin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Kanamycin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Kanamycin Market Absolute $ Opportunity
5. Global Kanamycin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Kanamycin Market Size and Volume Forecast by Type
5.3.1. Injection
5.3.2. Solution
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Kanamycin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Kanamycin Market Size and Volume Forecast by Application
6.3.1. Medical
6.3.2. Santific Research
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Kanamycin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Kanamycin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Kanamycin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Kanamycin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Kanamycin Demand Share Forecast, 2019-2026
9. North America Kanamycin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Kanamycin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Kanamycin Market Size and Volume Forecast by Application
9.4.1. Medical
9.4.2. Santific Research
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Kanamycin Market Size and Volume Forecast by Type
9.7.1. Injection
9.7.2. Solution
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Kanamycin Demand Share Forecast, 2019-2026
10. Latin America Kanamycin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Kanamycin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Kanamycin Market Size and Volume Forecast by Application
10.4.1. Medical
10.4.2. Santific Research
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Kanamycin Market Size and Volume Forecast by Type
10.7.1. Injection
10.7.2. Solution
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Kanamycin Demand Share Forecast, 2019-2026
11. Europe Kanamycin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Kanamycin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Kanamycin Market Size and Volume Forecast by Application
11.4.1. Medical
11.4.2. Santific Research
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Kanamycin Market Size and Volume Forecast by Type
11.7.1. Injection
11.7.2. Solution
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Kanamycin Demand Share, 2019-2026
12. Asia Pacific Kanamycin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Kanamycin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Kanamycin Market Size and Volume Forecast by Application
12.4.1. Medical
12.4.2. Santific Research
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Kanamycin Market Size and Volume Forecast by Type
12.7.1. Injection
12.7.2. Solution
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Kanamycin Demand Share, 2019-2026
13. Middle East & Africa Kanamycin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Kanamycin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Kanamycin Market Size and Volume Forecast by Application
13.4.1. Medical
13.4.2. Santific Research
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Kanamycin Market Size and Volume Forecast by Type
13.7.1. Injection
13.7.2. Solution
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Kanamycin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Kanamycin Market: Market Share Analysis
14.2. Kanamycin Distributors and Customers
14.3. Kanamycin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sigma-Aldrich
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. HiMedia
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Atlanta Biologicals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Takara
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PromoCell
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Zenbio
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Abcam
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook